article Open AccessTop 1% cited
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
Annals of Oncology · 2017 · Vol. 28(8) · pp. 1700–1712
Giuseppe Curigliano✉(European Institute of Oncology)Harold J. Burstein(Harvard University)Eric P. Winer(Harvard University)Michael Gnant(Comprehensive Cancer Center Vienna)Peter Dubsky(Medical University of Vienna)Sibylle Loibl(German Breast group)Marco Colleoni(European Institute of Oncology)Meredith M. Regan(Harvard University)Martine Piccart(Institut Jules Bordet)Hans-Jörg Senn(Breast Center)Beat Thürlimann(Kantonsspital St. Gallen)Fabrice André(Institut Gustave Roussy)José Baselga(Memorial Sloan Kettering Cancer Center)Jonas Bergh(Karolinska Institutet)Hervé Bonnefoi(Université de Bordeaux)Sara Y. Brucker(Universitäts Frauenklinik)Fátima Cardoso(Champalimaud Foundation)Lisa A. Carey(University of North Carolina at Chapel Hill)Eva Ciruelos(Hospital Universitario 12 De Octubre)Jack Cuzick(Queen Mary University of London)Carsten Denkert(Charité - Universitätsmedizin Berlin)Angelo Di Leo(Azienda Usl Toscana Centro)Bent Ejlertsen(Rigshospitalet)Prudence A. Francis(Peter MacCallum Cancer Centre)V.E. Galimberti(European Institute of Oncology)Judy E. Garber(Harvard University)Bahadır M. Güllüoğlu(Marmara University)Pamela J. Goodwin(Mount Sinai Hospital)Nadia Harbeck(Ludwig-Maximilians-Universität München)Daniel F. Hayes(University of Michigan–Ann Arbor)Chiun‐Sheng Huang(National Taiwan University Hospital)Jens Huober(Universität Ulm)Hussein Khaled(Cairo University)Jacek Jassem(Gdańsk Medical University)Zefei Jiang(Academy of Military Medical Sciences)Per Karlsson(Sahlgrenska University Hospital)Monica Morrow(Memorial Sloan Kettering Cancer Center)Roberto Orecchia(European Institute of Oncology)Kent C. Osborne(Baylor College of Medicine)Olivia Pagani(Ospedale San Giovanni Bellinzona)Ann H. Partridge(Dana-Farber Cancer Institute)K. Pritchard(Sunnybrook Health Science Centre)Jungsil Ro(National Cancer Center)Emiel J. Rutgers(The Netherlands Cancer Institute)Felix Sedlmayer(Paracelsus Medical University)Semiglazov Vf(Institute of Oncology NN Petrov)Zhi‐Ming Shao(Fudan University Shanghai Cancer Center)Ian Smith(Royal Marsden NHS Foundation Trust)Masakazu Toi(Kyoto University)Andrew Tutt(Institute of Cancer Research)Giuseppe Viale(European Institute of Oncology)Toru Watanabe(Hamamatsu Medical Center)Timothy J. Whelan(McMaster University)Binghe Xu(Beijing Chaoyang Emergency Medical Center)
Breast Cancer Treatment StudiesAdvanced Breast Cancer TherapiesCancer Risks and FactorsMedicineBreast cancerOncologyRadiation therapyCancerInternal medicineHormonal therapyAdjuvant therapyStage (stratigraphy)Neoadjuvant therapy
MeSH terms
Adjuvants, ImmunologicAntineoplastic AgentsAustriaBreast NeoplasmsCombined Modality TherapyFemaleHumansRadiotherapySurgical Procedures, OperativeNeoadjuvant TherapyEarly Diagnosis
Funding
- American Society for Radiation Oncology
Citations
1,245
FWCI
48.58
field-weighted impact
References
99
Percentile
100%
vs. same field & year
Citations per year
Cited by
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2019 · 2,185 citations
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2010 · 2,860 citations
Breast Cancer—Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature)
Cancers · 2022 · 508 citations
References
Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer
Annals of Surgical Oncology · 2014 · 608 citations
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
The Lancet Oncology · 2013 · 1,433 citations
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
Breast Cancer Research and Treatment · 2017 · 750 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
